173 related articles for article (PubMed ID: 38078010)
1. Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer.
Rivera-Cruz CM; Kumar S; Figueiredo ML
Front Cell Dev Biol; 2023; 11():1145421. PubMed ID: 38078010
[No Abstract] [Full Text] [Related]
2. Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells.
Rivera-Cruz CM; Figueiredo ML
Cytotherapy; 2023 Jan; 25(1):33-45. PubMed ID: 36257875
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
[TBL] [Abstract][Full Text] [Related]
4. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes.
Jammes M; Contentin R; Audigié F; Cassé F; Galéra P
Front Bioeng Biotechnol; 2023; 11():1204737. PubMed ID: 37720315
[No Abstract] [Full Text] [Related]
5. Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy.
Plava J; Cihova M; Burikova M; Bohac M; Adamkov M; Drahosova S; Rusnakova D; Pindak D; Karaba M; Simo J; Mego M; Danisovic L; Kucerova L; Miklikova S
Cells; 2020 Feb; 9(2):. PubMed ID: 32093026
[TBL] [Abstract][Full Text] [Related]
6. Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive
Roemeling-van Rhijn M; Khairoun M; Korevaar SS; Lievers E; Leuning DG; Ijzermans JN; Betjes MG; Genever PG; van Kooten C; de Fijter HJ; Rabelink TJ; Baan CC; Weimar W; Roelofs H; Hoogduijn MJ; Reinders ME
J Stem Cell Res Ther; 2013 Nov; Suppl 6(1):20780. PubMed ID: 24672744
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade.
Antoon R; Wang XH; Saleh AH; Warrington J; Hedley DW; Keating A
Cytotherapy; 2022 Jul; 24(7):699-710. PubMed ID: 35473998
[TBL] [Abstract][Full Text] [Related]
8. Effects of Stromal Cell Conditioned Medium and Antipurinergic Treatment on Macrophage Phenotype.
Arabiyat AS; Yeisley DJ; Güiza-Argüello VR; Qureshi F; Culibrk RA; Hahn J; Hahn MS
Tissue Eng Part C Methods; 2022 Dec; 28(12):656-671. PubMed ID: 36329666
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
[TBL] [Abstract][Full Text] [Related]
10. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.
Klopp AH; Zhang Y; Solley T; Amaya-Manzanares F; Marini F; Andreeff M; Debeb B; Woodward W; Schmandt R; Broaddus R; Lu K; Kolonin MG
Clin Cancer Res; 2012 Feb; 18(3):771-82. PubMed ID: 22167410
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
12. Human Adipose-Derived Mesenchymal Stromal Cells May Promote Breast Cancer Progression and Metastatic Spread.
Kamat P; Schweizer R; Kaenel P; Salemi S; Calcagni M; Giovanoli P; Gorantla VS; Eberli D; Andres AC; Plock JA
Plast Reconstr Surg; 2015 Jul; 136(1):76-84. PubMed ID: 26111315
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth.
Zolochevska O; Yu G; Gimble JM; Figueiredo ML
Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of mesenchymal stromal cells in gynecologic cancer therapy.
Song Y; Liu H; Pan S; Xiang X; Ye M; Zhu X
Stem Cell Res Ther; 2023 Dec; 14(1):347. PubMed ID: 38049868
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
Romieu-Mourez R; François M; Abate A; Boivin MN; Birman E; Bailey D; Bramson JL; Forner K; Young YK; Medin JA; Galipeau J
Cancer Res; 2010 Oct; 70(20):7742-7. PubMed ID: 20924101
[TBL] [Abstract][Full Text] [Related]
18. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.
Giallongo C; Tibullo D; Camiolo G; Parrinello NL; Romano A; Puglisi F; Barbato A; Conticello C; Lupo G; Anfuso CD; Lazzarino G; Li Volti G; Palumbo GA; Di Raimondo F
Cell Death Dis; 2019 Sep; 10(10):704. PubMed ID: 31541083
[TBL] [Abstract][Full Text] [Related]
19. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.
Rodini CO; Gonçalves da Silva PB; Assoni AF; Carvalho VM; Okamoto OK
Oncotarget; 2018 May; 9(37):24766-24777. PubMed ID: 29872504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
